[Sterolibrin therapy of endocrine deficiencies during induced climacteric in oncology].
D001341:Autonomic Nervous System; D002369:Castration / Q000009:adverse effects*; D002979:Climacteric; D003863:Depression / Q000188:drug therapy / Q000209:etiology; D004338:Drug Combinations; D005260:Female; D005833:Genital Neoplasms, Female / Q000601:surgery; D006801:Humans; D008656:Mestranol / Q000627:therapeutic use*; D009422:Nervous System Diseases / Q000188:drug therapy / Q000209:etiology; D011245:Pregnadienes / Q000627:therapeutic use*; D011372:Progestins / Q000627:therapeutic use*; D011795:Surveys and Questionnaires; D014626:Vaginal Smears
D004338:Drug Combinations; D011245:Pregnadienes; D011372:Progestins; D008656:Mestranol
Sterolibrin in der Behandlung von Ausfallerscheinungen während des künstlichen Klimakteriums in der Onkologie.